RBPMSLP

Across TCGA pan-cancer cohorts, RBPMSLP RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RBPMSLP data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RBPMSLP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RBPMSLP expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

ACC, UVM, and TGCT are the cancer types where RBPMSLP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	II,III,IV	0.189	0.665	<.001	96	view →
UVM	OS	Tertile	III,IV	0.037	0.809	<.001	54	view →
TGCT	DFS	Quartile	II,III,IV	0.586	0.996	.002	30	view →
THYM	DFS	Quartile	II,III,IV	0.646	0.946	.004	26	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	19	view →
HNSC	DFS	Quartile	All	0.481	0.280	.004	19	view →
READ	OS	Tertile	II,III,IV	0.622	0.945	.009	18	view →
BLCA	DFS	Tertile	III,IV	0.519	0.283	.019	14	view →
SKCM	OS	Quartile	II,III,IV	0.213	0.351	.027	9	view →
BRCA	DFS	Tertile	III,IV	0.361	0.560	.022	8	view →
STAD	DFS	Tertile	IV	0.130	0.551	.007	6	view →
LAML	DFS	Median	All	0.264	0.511	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RBPMSLP–ACC (DFS)

Open the ACC breakdown →